2'-Deoxy-5'-O-DMT-uridine

CAS : 23669-79-6

Ref. 3D-ND05965

Informations sur le produit

• Nom: 2'-Deoxy-5'-O-DMT-uridine
• Synonymes: 5'-O-DMT-dU5'-O-(4,4'-Dimethoxytrityl)-2'-deoxyuridine2'-Deoxy-5'-O-DMT-D-uridine5'-O-DMT-2'-deoxyuridine, 1-{5-O-[bis(4-methoxyphenyl)(phenyl)methyl]-2-deoxypentofuranosyl}pyrimidine-2,4(1H,3H)-dione, 5'-O-(4,4'-Dimethoxytrityl)-2'-Deoxyuridine, 5'-O-[Bis(4-Methoxyphenyl)Benzyl]-2'-Deoxyuridine, 5'-O-[bis(4-methoxyphenyl)(phenyl)methyl]-2'-deoxyuridine, 5′-O-(Dimethoxytrityl)-2′-deoxyuridine, 5′-O-[Bis(4-methoxyphenyl)phenylmethyl]-2′-deoxyuridine, Uridine, 5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-deoxy-, Uridine, 5′-O-[α,α-bis(p-methoxyphenyl)benzyl]-2′-deoxy-

Description

2'-Deoxy-5'-O-DMT-uridine is a bifunctional drug that has both antibacterial and anticancer activity. This drug is used to treat leishmania infections, which are caused by protozoan parasites. 2'-Deoxy-5'-O-DMT-uridine suppresses the growth of these organisms by inhibiting RNA synthesis and protein synthesis. It also inhibits proliferation of cancer cells in vivo by targeting cancer cells with high levels of primary amines. 2'-Deoxy-5'-O-DMT-uridine is an effective chemotherapeutic agent that can be used to treat pancreatic cancers with high rates of primary amines (e.g., insulinoma).

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 530.58 g/mol
• Formule: C₃₀H₃₀N₂O₇
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder